The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Such stuff as dreams are made on: mediator-directed therapy in sepsis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Self-citationBiologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Multiple Organ Dysfunction Score: A reliable descriptor of a complex clinical outcome
Marshall, J. C., Cook, D. J., Christou, N. V., Bernard, G. R., Sprung, C. L., & Sibbald, W. J. (1995) · Critical Care Medicine · doi:10.1097/00003246-199510000-00007 · Cited by 2,532
Self-citationAnti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448 · cited 1×
“, or that caused by the infusion of live Escherichia coli”
BackgroundBeutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Ziegler, E. J., Fisher, C. J., Sprung, C. L., Straube, R. C., Sadoff, J. C., Foulke, G. E., Wortel, C. H., Fink, M. P., Dellinger, R. P., Teng, N. N. H., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102143240701 · Cited by 1,611
A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients
Gattinoni, L., Brazzi, L., Pelosi, P., Latini, R., Tognoni, G., Pesenti, A., & Fumagalli, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331601 · Cited by 1,510
Association between mitochondrial dysfunction and severity and outcome of septic shock
Brealey, D., Brand, M., Hargreaves, I., Heales, S., Land, J., Smolenski, R., Davies, N. A., Cooper, C. E., & Singer, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09459-x · Cited by 1,503
Bone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., Balk, R. A., & The Methylprednisolone Severe Sepsis Study Group (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171101 · Cited by 1,440
High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,419
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H., & Braude, A. I. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072001 · Cited by 1,046
Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome
Casey, L. C., Balk, R. A., & Bone, R. C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-8-199310150-00001 · Cited by 1,041
Annane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000 · cited 1×
“Although adrenal haemorrhage or necrosis are rare in sepsis, a number of observational studies have established that functional adrenal insufficiency and an inability to augment adrenal cortisol release in response to ACTH stimulation are common, and associated with adverse outcom”
BackgroundSir Isaac Newton, sepsis, SIRS, and CARS
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00010 · Cited by 989
Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6952 · Cited by 934
López, A., Lorente, J. A., Steingrub, J., Bakker, J., McLuckie, A., Willatts, S., Brockway, M., Anzueto, A., Holzapfel, L., Breen, D., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000105581.01815.c6 · Cited by 921
Reversal of late septic shock with supraphysiologic doses of hydrocortisone
Bollaert, P.-E., Charpentier, C., Levy, B., Debouverie, M., Audibert, G., & Larcan, A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00010 · Cited by 872
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
The Effects of Ibuprofen on the Physiology and Survival of Patients with Sepsis
Bernard, G. R., Wheeler, A. P., Russell, J. A., Schein, R., Summer, W. R., Steinberg, K. P., Fulkerson, W. J., Wright, P. E., Christman, B. W., Dupont, W. D., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361303 · Cited by 837
Genetic and Environmental Influences on Premature Death in Adult Adoptees
Sørensen, T. I. A., Nielsen, G. G., Andersen, P. K., & Teasdale, T. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181202 · Cited by 827
Sprung, C. L., Caralis, P. V., Marcial, E. H., Pierce, M., Gelbard, M. A., Long, W. M., Duncan, R. C., Tendler, M. D., & Karpf, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111801 · Cited by 765
Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever
Cannon, J. G., Tompkins, R. G., Gelfand, J. A., Michie, H. R., Stanford, G. G., van der Meer, J. W. M., Endres, S., Lonnemann, G., Corsetti, J., Chernow, B., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.1.79 · Cited by 751
Mira, J.-P., Cariou, A., Grall, F., Delclaux, C., Losser, M.-R., Heshmati, F., Cheval, C., Monchi, M., Teboul, J.-L., Riché, F., et al. (1999) · JAMA · doi:10.1001/jama.282.6.561 · Cited by 740
Septic Shock, Multiple Organ Failure, and Disseminated Intravascular Coagulation
Fourrier, F., Chopin, C., Goudemand, J., Hendrycx, S., Caron, C., Rime, A., Marey, A., & Lestavel, P. (1992) · Chest · doi:10.1378/chest.101.3.816 · Cited by 708
The Veterans Administration Systemic Sepsis Cooperative Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171102 · Cited by 706
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.
Bone, R. C., Fisher, C. J., Clemmer, T. P., Gj, S., METZ, C. A., & BALK, R. A. (1989) · PubMed · Cited by 689
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects
van der Poll, T., Büller, H. R., ten Cate, H., Wortel, C. H., Bauer, K. A., van Deventer, S. J. H., Hack, C. E., Sauerwein, H. P., Rosenberg, R. D., & ten Cate, J. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222302 · Cited by 667
Toll signaling pathways in the innate immune response
Anderson, K. V. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00045-x · Cited by 632
Abraham, E. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80009-4 · Cited by 624
Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
Cronin, L., Cook, D. J., Carlet, J., Heyland, D. K., King, D. B. M., Lansang, M. A. D., & Fisher, Jr. (1995) · Critical Care Medicine · doi:10.1097/00003246-199508000-00019 · Cited by 622
Abraham, E. H., Anzueto, A., Gutiérrez, G., Tessler, S., Pedro, G. S. S., Wunderink, R. G., Nogare, A. R. D., Nasraway, S. A., Berman, S., Cooney, R. N., et al. (1998) · PubMed · Cited by 622
Keh, D., Boehnke, T., Weber-Cartens, S., Schulz, C., Ahlers, O., Bercker, S., Volk, H.-D., Doecke, W.-D., Falke, K. J., & Gerlach, H. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200205-446oc · Cited by 600
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
Arend, W. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115453 · Cited by 595
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
Steroids in the Treatment of Clinical Septic Shock
SCHUMER, W. (1976) · Annals of Surgery · doi:10.1097/00000658-197609000-00011 · Cited by 545
Sepsis syndrome: A valid clinical entity
BONE, R. C., FISHER, C. J., CLEMMER, T. P., SLOTMAN, G. J., METZ, C. A., & BALK, R. A. (1989) · Critical Care Medicine · doi:10.1097/00003246-198905000-00002 · Cited by 537
Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
Tjoelker, L. W., Wilder, C., Eberhardt, C., Stafforinit, D. M., Dietsch, G., Schimpf, B., Hooper, S., Trong, H. L., Cousens, L. S., Zimmerman, G. A., et al. (1995) · Nature · doi:10.1038/374549a0 · Cited by 526
Murakami, M., & Kudo, I. (2002) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003101 · Cited by 507
Cohen, J., & Carlet, J. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00002 · Cited by 501
McCloskey, R. V., Straube, R. C., Sanders, C., Smith, S. M., Smith, C. R., & and CHESS Trial Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-1-199407010-00001 · Cited by 495
Fisher, C. J., Slotman, G. J., Opal, S. M., Pribble, J. P., Bone, R. C., Emmanuel, G., Ng, D., Bloedow, D. C., & Catalano, M. A. (1994) · Critical Care Medicine · doi:10.1097/00003246-199401000-00008 · Cited by 490
Corticosteroid Therapy in Severe Illness
Lamberts, S. W. J., Bruining, H. A., & de Jong, F. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710303371807 · Cited by 488
Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans
DAMAS, P., REUTER, A., GYSEN, P., DEMONTY, J., LAMY, M., & FRANCHIMONT, P. (1989) · Critical Care Medicine · doi:10.1097/00003246-198910000-00001 · Cited by 486
Dear SIRS, I'm sorry to say that I don't like you
Vincent, J.-L. (1997) · Critical Care Medicine · doi:10.1097/00003246-199702000-00029 · Cited by 444
FISHER, C. J., OPAL, S. M., DHAINAUT, J.-F., STEPHENS, S., ZIMMERMAN, J. L., NIGHTINGALE, P., HARRIS, S. J., SCHEIN, R. M. H., PANACEK, E. A., VINCENT, J.-L., et al. (1993) · Critical Care Medicine · doi:10.1097/00003246-199303000-00006 · Cited by 427
Cortisol response to corticotropin and survival in septic shock
ROTHWELL, P. (1991) · The Lancet · doi:10.1016/0140-6736(91)91641-7 · Cited by 412
Levin, M., Quint, P. A., Goldstein, B., Barton, P., Bradley, J. S., Shemie, S., Yeh, T., Kim, S. S., Cafaro, D. P., Scannon, P. J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02712-4 · Cited by 411
Baumgartner, J.-D., Mccutchan, J. A., Van Melle, G., Vogt, M., Luethy, R., Glauser, M., Ziegler, E., Klauber, M., Muehlen, E., Chiolero, R., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90176-x · Cited by 375
Reinhart, K., Wiegand-Lohnert, C., Grimminger, F., Kaul, M., Withington, S., Treacher, D., Eckart, J., Willatts, S., Bouza, C., Krausch, D., et al. (1996) · Critical Care Medicine · doi:10.1097/00003246-199605000-00003 · Cited by 361
Zimmerman, G. A., McIntyre, T. M., Prescott, S. M., & Stafforini, D. M. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205001-00020 · Cited by 358
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings
(1989) · Journal of Critical Care · doi:10.1016/0883-9441(89)90142-1 · Cited by 357
Borrelli, E., Roux-Lombard, P., Grau, G. E., Girardin, E., Ricou, B., Dayer, J.-M., & Suter, P. M. (1996) · Critical Care Medicine · doi:10.1097/00003246-199603000-00006 · Cited by 349
Johnson, C. D., Kingsnorth, A. N., Imrie, C. W., McMahon, M. J., Neoptolemos, J. P., McKay, C., Toh, S. K. C., Skaife, P., Leeder, P. C., Wilson, P., et al. (2001) · Gut · doi:10.1136/gut.48.1.62 · Cited by 347
Eisele, B., Heinrichs, H., Delvos, U., Lamy, M., Thijs, L. G., Keinecke, H. O., Schuster, H. P., Matthias, F. R., & Fourrier, F. (1998) · Intensive Care Medicine · doi:10.1007/s001340050642 · Cited by 336
Plasma tumor necrosis factor and mortality in critically ill septic patients
DEBETS, J. M. H., KAMPMEIJER, R., P, M., BUURMAN, W. A., & VAN DER LINDEN, C. J. (1989) · Critical Care Medicine · doi:10.1097/00003246-198906000-00001 · Cited by 321
E5531, a Pure Endotoxin Antagonist of High Potency
Christ, W. J., Asano, O., Robidoux, A. L. C., Perez, M., Wang, Y., Dubuc, G. R., Gavin, W. E., Hawkins, L. D., McGuinness, P. D., Mullarkey, M. A., et al. (1995) · Science · doi:10.1126/science.7701344 · Cited by 318
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Alejandria, M. M., Lansang, M. A. D., Dans, L. F., & Mantaring III, J. B. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001090 · Cited by 313
Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.
Gregory, S. A., Morrissey, J. H., & Edgington, T. S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2752 · Cited by 306
Abraham, E., Laterre, P.-F., Garbino, J., Pingleton, S., Butler, T., Dugernier, T., Margolis, B., Kudsk, K., Zimmerli, W., Anderson, P., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200103000-00006 · Cited by 293
Ely, E. W., Laterre, P.-F., Angus, D. C., Helterbrand, J. D., Levy, H., Dhainaut, J.-F., Vincent, J.-L., Macias, W. L., & Bernard, G. R. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301000-00002 · Cited by 283
Shock and Multiple-Organ Dysfunction after Self-Administration of Salmonella Endotoxin
da Silva, A. M. T., Kaulbach, H. C., Chuidian, F. S., Lambert, D. R., Suffredini, A. F., & Danner, R. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282005 · Cited by 276
Dhainaut, J.-F. A., Tenaillon, A., Le Tulzo, Y., Schlemmer, B., Solet, J.-P., Wolff, M., Holzapfel, L., Zeni, F., Dreyfuss, D., Mira, J.-P., et al. (1994) · Critical Care Medicine · doi:10.1097/00003246-199411000-00005 · Cited by 269
Riddington, D. W. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530370045029 · Cited by 266
Methylene blue administration in septic shock: A clinical trial
Preiser, J.-C., Lejeune, P., Roman, A., Carlier, E., De Backer, D., Leeman, M., Kahn, R. J., & Vincent, J.-L. (1995) · Critical Care Medicine · doi:10.1097/00003246-199502000-00010 · Cited by 263
Tilg, H., Vannier, E., Vachino, G., Dinarello, C. A., & Mier, J. W. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1629 · Cited by 256
Hinshaw, L. B., Tekamp-Olson, P., Chang, A. C. K., Lee, P. A., Taylor, F. B., Murray, C. K., Peer, G., Emerson, T. E., Passey, R. B., & Kuo, G. C. (1990) · PubMed · Cited by 239
Kingsnorth, A. N., Galloway, S. W., & Formela, L. J. (1995) · Journal of British Surgery · doi:10.1002/bjs.1800821039 · Cited by 233
Smith, O., White, B., Vaughan, D., Rafferty, M., Claffey, L., Lyons, B., & Casey, W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06356-3 · Cited by 233
The Primary Role of Lymphoreticnlar Cells in the Mediation of Host Responses to Bacterial Endotoxim
Michalek, S. M., Moore, R. N., McGhee, J. R., Rosenstreich, D. L., & Mergenhagen, S. E. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/141.1.55 · Cited by 210
Nelson, S., Belknap, S. M., Carlson, R. W., Dale, D., DeBoisblanc, B., Farkas, S., Fotheringham, N., Ho, H., Marrie, T., Movahhed, H., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515694 · Cited by 204
Grover, R., Zaccardelli, D., Colice, G., Guntupalli, K., Watson, D., & Vincent, J.-L. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00025 · Cited by 198
Hotchkiss, R. S., Schmieg, R. E., Swanson, P. E., Freeman, B. D., Tinsley, K. W., Cobb, J. P., Karl, I. E., & Buchman, T. G. (2000) · Critical Care Medicine · doi:10.1097/00003246-200009000-00016 · Cited by 198
Root, R. K., Lodato, R. F., Patrick, W., Cade, J. F., Fotheringham, N., Milwee, S., Vincent, J.-L., Torres, A., Rello, J., & Nelson, S. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000048629.32625.5d · Cited by 196
Leibovici, L. (2001) · BMJ · doi:10.1136/bmj.323.7327.1450 · Cited by 195
Effect of ibuprofen in patients with severe sepsis: A randomized, double-blind, multicenter study
HAUPT, M. T., JASTREMSKI, M. S., CLEMMER, T. P., METZ, C. A., & GORIS, G. B. (1991) · Critical Care Medicine · doi:10.1097/00003246-199111000-00006 · Cited by 180
Garcia-Carbonero, R., Mayordomo, J. I., Tornamira, M. V., Lopez-Brea, M., Rueda, A., Guillem, V., Arcediano, A., Yubero, A., Ribera, F., Gomez, C., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.31 · Cited by 177
Dephosphorylation of endotoxin by alkaline phosphatase in vivo.
Poelstra, K., Bakker, W. W., Klok, P. A., Kamps, J. A. A. M., Hardonk, M., & Meijer, D. K. F. (1997) · Europe PMC (PubMed Central) · Cited by 174
Fein, A. M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540300050033 · Cited by 173
Fessler, M. B., Malcolm, K. C., Duncan, M. W., & Worthen, G. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200755200 · Cited by 169
Kox, W. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440250031004 · Cited by 160
Ryu, J., Pyo, H., Jou, I., & Joe, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001220200 · Cited by 158
New strategies for clinical trials in patients with sepsis and septic shock
Cohen, J., Guyatt, G., Bernard, G. R., Calandra, T., Cook, D., Elbourne, D., Marshall, J., Nunn, A., & Opal, S. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104000-00039 · Cited by 158
Self-citationDhainaut, J.-F., Tenaillon, A., Hemmer, M., Damas, P., Tulzo, Y. L., Radermacher, P., Schaller, M., Sollet, J.-P., Wolff, M., Holzapfel, L., et al. (1998) · Critical Care Medicine · doi:10.1097/00003246-199812000-00021 · Cited by 153
Esmon, C. T. (2000) · Critical Care Medicine · doi:10.1097/00003246-200009001-00010 · Cited by 152
Tumor necrosis factor-α antagonists for the treatment of rheumatic diseases
Criscione‐Schreiber, L. G., & Clair, E. W. S. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200205000-00002 · Cited by 151
Touqui, L., & Alaoui-El-Azher, M. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363258 · Cited by 151
Bernard, G. R., Reines, H. D., Halushka, P. V., Higgins, S. B., Metz, C. A., Swindell, B. B., Wright, P. E., Watts, F. L., & Vrbanac, J. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1095 · Cited by 150
CDP571, a humanized antibody to human tumor necrosis factor-alpha
Dhainaut, J.-F., Vincent, J., Richard, C., Lejeune, P., Martin, C., Fierobe, L., Stephens, S., Ney, U. M., & Sopwith, M. (1995) · Critical Care Medicine · doi:10.1097/00003246-199509000-00004 · Cited by 148
Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins
Flegel, W. A., Wolpl, A., Männel, D. N., & Northoff, H. (1989) · Infection and Immunity · doi:10.1128/iai.57.7.2237-2245.1989 · Cited by 148
LETHAL STAPHYLOCOCCUS AUREUS-INDUCED SHOCK IN PRIMATES
Hinshaw, L. B., Emerson, T. E., Taylor, F. B., Chang, A. C. K., Duerr, M. L., Peer, G. T., Flournoy, D. J., White, G. L., Kosanke, S. D., Murray, C. K., et al. (1992) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199210000-00013 · Cited by 143
Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis
Esmon, C. T. (1999) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.1999.0029 · Cited by 136
Warren, H. S., Amato, S. F., Fitting, C., Black, K. M., Loiselle, P. M., Pasternack, M. S., & Cavaillon, J. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.1.89 · Cited by 128
Clark, M. A., Plank, L. D., Connolly, A. B., Streat, S., Hill, A. A. V., Gupta, R., Monk, D. N., Shenkin, A., & Hill, G. L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199810000-00016 · Cited by 126
A Controlled Trial of HA-1A in a Canine Model of Gram-negative Septic Shock
Quezado, Z. (1993) · JAMA · doi:10.1001/jama.1993.03500170051033 · Cited by 116
Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
Petros, A., Marshall, J. C., & van Saene, H. K. F. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90347-x · Cited by 114
Self-citationClinical trials of mediator-directed therapy in sepsis: what have we learned?
Marshall, J. C. (2000) · Intensive Care Medicine · doi:10.1007/s001340051122 · Cited by 113
Self-citationLipid mediators in the pathophysiology of critical illness
Bulger, E. M., & Maier, R. V. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004001-00004 · Cited by 109
Oppert, M., Reinicke, A., Gräf, K.-J., Barckow, D., Frei, U. A., & Eckardt, K. (2000) · Intensive Care Medicine · doi:10.1007/s001340000685 · Cited by 104
Immunomodulation in Septic Shock
Briegel, J., JOCHUM, M., Gippner‐Steppert, C., & Thiel, M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12suppl_1s70 · Cited by 103
C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction
Caliezi, C., Zeerleder, S. S., Redondo, M., Regli, B., Rothen, H.-U., Zenklusen, R. M. Z., Rieben, R., Devay, J., Hack, C. E., Lämmle, B., et al. (2002) · Critical Care Medicine · doi:10.1097/00003246-200208000-00008 · Cited by 99
Andresen, M., Dougnac, A., Orlando Díaz, P., Hernandez, G., Castillo, L., Bugedo, G. J., Álvarez, M. A., & Dagnino, J. A. (1998) · Journal of Critical Care · doi:10.1016/s0883-9441(98)90001-6 · Cited by 97
Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays
Zhao, B., Bowden, R. A., Stavchansky, S. A., & Bowman, P. D. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.5.c1587 · Cited by 87
Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients.
Hershman, M. J., Appel, S. H., Wellhausen, S. R., et al. (1989) · PubMed · Cited by 84
Grover, R., Lopez, A., Lorente, J. A., Steingrub, J. S., Bakker, J., Willatts, S. M., McLuckie, A., & Takala, J. A. (1999) · Critical Care Medicine · doi:10.1097/00003246-199901001-00021 · Cited by 83
Vincent, J., Spapen, H. D., Bakker, J., Webster, N. R., & Curtis, L. D. (2000) · Critical Care Medicine · doi:10.1097/00003246-200003000-00006 · Cited by 82
Nelson, S., Heyder, A., Stone, J., Bergeron, M. G., Daugherty, S. K., Peterson, G. M., Fotheringham, N., Welch, W., Milwee, S., Root, R. K., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315775 · Cited by 82
Low-Dose Heparin for Severe Sepsis
Davidson, B. L., Geerts, W. H., & Lensing, A. W. A. (2002) · New England Journal of Medicine · doi:10.1056/nejm200209263471316 · Cited by 81
Corticosteroids in septic shock
Matot, I., & Sprung, C. L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00002 · Cited by 76
Endotoxemia after major vascular operations.
Roumen, R., Frieling, J., van Tits, H. W. H. J., van der Vliet, J. A., & Goris, R. A. (1993) · Journal of Vascular Surgery · doi:10.1016/0741-5214(93)90341-i · Cited by 75
Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses.
Briegel, J., Jochum, M., Gippner‐Steppert, C., & Thiel, M. (2001) · PubMed · Cited by 75
WILDE, C. G., Seilhamer, J. J., McGrogan, M. P., Ashton, N. M., Snable, J. L., Lane, J. C., Leong, S. R., Thornton, M. B., Miller, K. L., & Scott, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32454-7 · Cited by 72
From the Bench to the Bedside: The Future of Sepsis Research
Physicians, C. (1997) · CHEST Journal · doi:10.1378/chest.111.3.744 · Cited by 69
Pharmacodynamics of active site‐inhibited factor VIIa in endotoxin‐induced coagulation in humans
Jilma, B., Marsik, C. L., Mayr, F., Graninger, M., Taylor, F. B., Ribel, M. C., Erhardtsen, E., Handler, S., & Eichler, H. G. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127740 · Cited by 68
Sepsis research: We must change course
Nasraway, S. A. (1999) · Critical Care Medicine · doi:10.1097/00003246-199902000-00054 · Cited by 67
Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome
Willatts, S. M., Radford, S. F., & Leitermann, M. (1995) · Critical Care Medicine · doi:10.1097/00003246-199506000-00007 · Cited by 64
Appoloni, O., Dupont, E., Vandercruys, M., Andriens, M., Duchateau, J., & Vincent, J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00656-8 · Cited by 64
Weingartner, R., de Oliveira, E. C. L., Oliveira, E. S., Sant'Anna, U. L., Oliveira, R., Azambuja, L. A., & Friedman, G. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999001200009 · Cited by 63
Dellinger, R. P., Opal, S. M., Rotrosen, D., Suffredini, A. F., Zimmerman, J. L., Bone, R. C., Bosken, C. H., Goldstein, R. A., Hurd, S. S., Vincent, J., et al. (1997) · PubMed · Cited by 62
Albertson, T. E., Panacek, E. A., MacArthur, R. D., Johnson, S. B., Benjamin, E., Matuschak, G. M., Zaloga, G. P., Maki, D. G., Silverstein, J. H., Tobias, J. K., et al. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000045564.51812.3f · Cited by 61
The Human Response to Endotoxin
Lin, E., & Lowry, S. F. (1998) · Sepsis · doi:10.1023/a:1009890031293 · Cited by 61
Meduri, G. U. (1999) · Sepsis · doi:10.1023/a:1009870524359 · Cited by 59
Poeze, M., Froon, A. H. M., Ramsay, G., Buurman, W. A., & Greve, J. W. M. (2000) · Shock · doi:10.1097/00024382-200014040-00001 · Cited by 59
Gallagher, J. J., Fisher, C. J., Sherman, B. W., Munger, M. A., Meyers, B., Ellison, T., Fischkoff, S. A., Barchuk, W., Teoh, L. S., & Velagapudi, R. B. (2001) · Intensive Care Medicine · doi:10.1007/s001340100973 · Cited by 58
Intravenous immunoglobulin for prophylaxis and therapy of sepsis
Werdan, K. (2001) · Current Opinion in Critical Care · doi:10.1097/00075198-200110000-00007 · Cited by 58
Suputtamongkol, Y., Intaranongpai, S., Smith, M. D., Angus, B., Chaowagul, W., Permpikul, C., Simpson, J. A., Leelarasamee, A., Curtis, L. D., & White, N. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.693-696.2000 · Cited by 56
Another negative clinical trial of a new agent for the treatment of sepsis
Fink, M. P. (1995) · Critical Care Medicine · doi:10.1097/00003246-199506000-00001 · Cited by 56
Signal Transduction by Tumor Necrosis Factor
Goeddel, D. V. (1999) · CHEST Journal · doi:10.1378/chest.116.suppl_1.69s · Cited by 52
Avontuur, J. A. M., Stam, T. C., Eggermont, A. M. M., Braining, H. A., Jongen‐Lavrencic, M., & van Amsterdam, J. (1998) · Intensive Care Medicine · doi:10.1007/s001340050643 · Cited by 35
GRANULOCYTE COLONY-STIMULATING FACTOR AND MODULATION OF INFLAMMATORY CELLS IN SEPSIS
Nelson, S., & Bagby, G. J. (1996) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70317-8 · Cited by 33
Sepsis and controlled clinical trials
Bone, R. C. (1995) · Critical Care Medicine · doi:10.1097/00003246-199508000-00001 · Cited by 31
Froon, A. H. M., Greve, J. W. M., Buurman, W. A., van der Linden, J., Langemeijer, H. J. M., Ulrich, C., & Bourgeois, M. (1996) · Shock · doi:10.1097/00024382-199605000-00001 · Cited by 31
Dackiw, A. P. B., Nathens, A. B., Marshall, J., & Rotstein, O. D. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0330 · Cited by 24
Self-citationRethinking Sepsis: From Concepts to Syndromes to Diseases
Marshall, J. C. (1999) · Sepsis · doi:10.1023/a:1009830809222 · Cited by 23
Self-citationAn Update on Inhibitors of Human 14 kDa Type II s-PLA2 in Development>
Springer, D. M. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013398275 · Cited by 20
Cited by
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Annane, D., Bellissant, E., & Cavaillon, J.-M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,213
Animal Models of sepsis: setting the stage
Buras, J. A., Holzmann, B., & Sitkovsky, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 843
Why have clinical trials in sepsis failed?
Marshall, J. C. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.007 · Cited by 805
Self-citationJia, S. H., Li, Y., Parodo, J., Kapus, A., Fan, L., Rotstein, O. D., & Marshall, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19930 · Cited by 598
Self-citation
Metadata
- Authors
- Marshall, J. C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-05-01
- Volume
- 2
- Issue
- 5
- Pages
- 391-405
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1980123081
- Cited by
- 264
- References
- 150
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.